Drug recall · May 8, 2013
Pantoprazole Sodium Delayed Release Tablets USP recall
Why: cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India ;Marketed by Jubilant Cadista Pharmaceuatical Inc Salisbury, MD 21801 NDC 59746-284-90
- Lots / codes
Lot PA22028 Exp 5/2014 Lot PA22029 Exp 5/2014
- Quantity
- 12770 bottles
- Company
- Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD
- Distribution
- Nationwide
- Initiated
- February 11, 2013 · Voluntary: Firm initiated
- Classified
- April 26, 2013
- Reported
- May 8, 2013
- Ended
- December 23, 2013
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pantoprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.